Investigation of the Efficacy of Metacognitive Training for Patients with Long-COVID - A Randomized Controlled Trial

Not Applicable

Recruiting

Conditions: U09.9
Post COVID-19 condition, unspecified

Registration Number: DRKS00032218

Lead Sponsor: Klinikum Christophsbad, Akademie für Psychotherapie (C-AP), Forschungssektion für Angewandte Psychotherapie und Psychiatrie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Minimum age: 18 years
Fluent in written and spoken German (to ensure understanding of diagnostic assessments and intervention).
Confirmed COVID-19 infection in the past, proven by a laboratory test (U07.1!)

Exclusion Criteria

Acute suicidality
Acute danger to others
Acute self-harm
Bipolar disorders (current or past episodes)
Schizophrenic disorders (current or past episodes)
Current psychotherapy, or unwillingness to pause current psychotherapy for the duration of the study (from T1 to T3)
Consumption of addictive substances other than alcohol and nicotine in the past 3 months
Presence of a addiction disease

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Metacognitive skills (assessed by: Metacognition Questionnaire-30 (MCQ-30); Arndt et al., 2011).<br><br>Long-COVID related quality of life (assessed by: Post Acute Covid-19 Quality of Life (PAC-19QoL); Jandhyala, 2021)<br><br>Both primary endpoints will be assessed one week before the intervention starts (T0), one week after the intervention (T1), and at the follow-up time point (T2). In the control group, assessments will be conducted analogous to the intervention group.

Secondary Outcome Measures

Name	Time	Method
Depressive symptoms (assessed by: Beck Depression Inventory-II (BDI-II); Hautzinger, Keller & Kühner, 2006)<br><br>Illness-related anxieties and depressions (assessed by: Hospital Anxiety and Depression Scale (HADS); Zigmond & Snaith, 1983)<br><br>General quality of life (assessed by: World Health Organization - Quality of Life (WHOQOL-BREF); WHO Group, 1998)<br><br>All three secondary endpoints will be assessed one week before the intervention starts (T0), one week after the intervention (T1), and at the follow-up time point (T2). In the control group, assessments will be conducted analogous to the intervention group.